D. E. Shaw & Co., Inc. Puma Biotechnology, Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2020 May 15, 2020	SELL	$6.28 - $14.57 $376,800 - $874,200	-60,000 Reduced 67.95%	28,300 $239,000
Q3 2019 Nov 14, 2019	BUY	$8.75 - $12.85 $488,250 - $717,030	55,800 Added 171.69%	88,300 $951,000
Q4 2017 Feb 14, 2018	BUY	$93.85 - $132.45 $1.17 Million - $1.66 Million	12,500 Added 62.5%	32,500 $3.21 Million
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $1.44 Million - $2.4 Million	20,000	20,000 $2.4 Million

107

32.2M

43.4K

3.7K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $126M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.